Showing results (151-160 of 267) with videos related to

Sort By:
Pageof 27
Plos One|October 17, 2012
Future impact of various interventions on the burden of COPD in Canada: a dynamic population modelMehdi Najafzadeh, Carlo A Marra, Larry D Lynd, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 11, 2023
Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in CanadaJoseph E Amegadzie, Tae Yoon Lee, Mohsen Sadatsafavi, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 26, 2019
Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for CanadaMohsen Sadatsafavi, Shahzad Ghanbarian, Amin Adibi, et al.
BMJ Open|February 22, 2019
Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort studyNicole W Tsao, Larry D Lynd, Eric C Sayre, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|October 13, 2021
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in CanadaMohsen Sadatsafavi, J Mark FitzGerald, Paul M O'Byrne, et al.
The Journal of Allergy and Clinical Immunology|December 15, 2019
Cost-effectiveness of implementing objective diagnostic verification of asthma in the United StatesMohsen Yaghoubi, Amin Adibi, Zafar Zafari, et al.
Respiratory Medicine|September 12, 2020
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UKJ Mark FitzGerald, Sofie Arnetorp, Caitlin Smare, et al.
The Lancet. Respiratory Medicine|March 18, 2020
The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling studyAmin Adibi, Don D Sin, Abdollah Safari, et al.
Journal of Cancer Policy|July 20, 2024
Real-world cost-effectiveness of panel-based genomic testing to inform therapeutic decisions for metastatic colorectal cancerReka E Pataky, Deirdre Weymann, Ian Bosdet, et al.
BMJ Open|September 18, 2017
Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation studyAnik R Patel, Jonathon R Campbell, Mohsen Sadatsafavi, et al.
Pageof 27